Chronicle Journal: Finance

Edwards Lifesciences: Near-Term Techno-Fundamental Metrics

Though Edwards Lifesciences looks like a long-term investment pick, its near-term price action on the charts suggests that it is weakening. Option chain data also suggest the upside is capped.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.